Company Overview
RareCyte is an innovative, microenvironment-focused company that has developed technologies and end-to-end integrated platforms to accelerate research in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Trusted as a one-stop resource in spatial transcriptomics and liquid biopsy, RareCyte is widely utilized in research, translational medicine, and clinical institutions. The company’s highly multiplexed fluorescence imaging systems, reagents, and contract services enable researchers to uncover the spatial context of critical biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.
Research Highlights
Here are some featured studies:
- Poster evaluating neoadjuvant therapy in colorectal cancer patients, presented at ASCO GI 2024
- Poster exploring multiplex data for investigation of multiple tissue types, presented at AACR 2024
- Poster exploring the quantitative analysis of colorectal adenocarcinoma, presented at AACR 2024
- Poster exploring tumor intrinsic features in multi-tumor tissue microarrays, presented at AACR 2024
Featured Article
Contact Us
For more information about our products and services, please visit yamato-net.co.jp.